MTCI
SEMINAR
Targets, Tissues and Trials’
You are cordially invited to a
Translational Cancer Research Seminar
with International Guest Speakers:
Prof. Lajos Pusztai, Dr. Constance Albarracin, Prof. Donald A. Berry
Chaired by Dr. Cathy Kelly, Consultant Oncologist,
Mater Misericordiae University Hospital
Date: Thursday 13th October 2011
Time: 6.00 - 8.30pm
Location: Herbert Park Hotel, Ballsbridge, Dublin 4
Presentation:
6pm “Discovery and evaluation of gene expression-based predictors of response to therapy”
Prof. Lajos Pusztai, MD, DPhil, Medical Oncologist & Lead of the Pharmacogenomic Program, Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, USA
6.40pm “Getting the biomarker to clinic: Identification, Validation and Image Analysis using immunohistochemical platforms”
Dr. Constance Albarracin, MD, Ph.D, Consultant Pathologist, Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston Texas, USA
7.20pm “The target, the drug, the patient, the dose: Adaptive Clinical Trial Designs”
Prof. Donald A. Berry, Ph.D, Department of Biostatics of the University of Texas M.D. Anderson Cancer
Center, Faculty statistician on the Breast Cancer Committee of the Cancer and Leukemia Group B (CALGB)
MTCI is a Science Foundation Ireland funded Strategic Research Cluster
To reserve your place please contact:
Email: (JavaScript must be enabled to view this email address)
Website: http://www.mtci.ie
|
|
